Heald et al v. H-E-B, LP et al
| maria heald, jeffrey alexander heald, nicholas matthew heald and sean louis heald |
| H-E-B, LP, Chattem, Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation, GlaxoSmithKline, LLC, glaxosmithkline holdings (americas) inc, Inc Pfizer, Sanofi-Aventis US LLC, Sanofi US Services, Inc., patheon manufacturing services, llc, Boehringer Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline Holdings (Americas) Inc., Pfizer Inc. and Patheon Manufacturing Services LLC |
| 1:2023cv00018 |
| January 13, 2023 |
| US District Court for the Eastern District of Texas |
| Michael J Truncale |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1441 Petition for Removal- Personal Injury |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 18, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| ACKNOWLEDGMENT OF RECEIPT of transfer to the Southern District of Florida case no. 3:23cv23054 filed 4/17/23. (kcv, ) |
| Filing 27 TRANSFER ORDER transferring case to the Southern District of Florida for inclusion in MDL 2924 IN RE: ZANTAC (RANITIDINE) PRODUCTS LIABILITY LITIGATION and assigned to the Honorable Robin L. Rosenberg. (signed by Clerk of the Panel) (kcv, ) |
| INTER-DISTRICT TRANSFER to the Southern District of Florida entered on 4/13/23. (kcv, ) |
| Filing 26 CORPORATE DISCLOSURE STATEMENT filed by Pfizer Inc. (Brown, Clarkson) |
Filing 25
ORDER granting the #20 Agreed Motion to Extend Rule 26 Deadlines. Rule 16 Case Management/Scheduling Conference reset for 4/28/2023 10:00 AM in Room 221 before District Judge Michael J. Truncale. It is ordered that the Rule 26(f) Attorney Conference is to be held on or before April 7, 2023, and the Joint Report of Attorney Conference and proposed Scheduling Order is to be filed on or before April 21, 2023. Signed by District Judge Michael J. Truncale on 2/8/23. (kcv, )
|
| Filing 24 RESPONSE in Opposition re #12 Opposed MOTION to Remand to State Court Defendants' Opposition to Plaintiffs' Expedited Motion to Remand filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, Chattem, Inc., GlaxoSmithKline Holdings (Americas) Inc., GlaxoSmithKline, LLC, Patheon Manufacturing Services LLC, Pfizer Inc., Sanofi US Services, Inc., Sanofi-Aventis US LLC. (Renfroe, Tracie) (Additional attachment(s) added on 2/17/2023: #1 Text of Proposed Order) (kcv, ). |
| Filing 23 RESPONSE to Motion re #15 Opposed MOTION to Seal Exhibit to Plaintiffs' Expedited Motion to Remand Manufacturer Defendants' Response to Motion to Seal filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, Chattem, Inc., GlaxoSmithKline Holdings (Americas) Inc., GlaxoSmithKline, LLC, Patheon Manufacturing Services LLC, Pfizer Inc., Sanofi US Services, Inc., Sanofi-Aventis US LLC. (Renfroe, Tracie) |
| Filing 22 NOTICE of Attorney Appearance - Pro Hac Vice by Andrew T Bayman on behalf of Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation. Filing fee $ 100, receipt number ATXEDC-9345157. (Bayman, Andrew) |
| Filing 21 CORPORATE DISCLOSURE STATEMENT filed by Patheon Manufacturing Services LLC (Garrett, John) |
| Filing 20 Agreed MOTION to Extend Rule 26 Deadlines by Sanofi US Services, Inc.. (Attachments: #1 Text of Proposed Order proposed Order)(Yoes, Stuart) Modified title on 2/7/2023 (kcv, ). |
| Filing 19 CORPORATE DISCLOSURE STATEMENT filed by H-E-B, LP (Hudson, Timothy) |
|
Filing 18
ORDER denying #17 Motion to Stay Proceedings Pending Transfer to Multidistrict Litigation No. 2924. Signed by District Judge Michael J. Truncale on 1/30/23. (kcv, )
|
| Filing 17 MOTION to Stay Proceedings Pending Transfer to Multidistrict Litigation No. 2924 by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, Chattem, Inc., GlaxoSmithKline Holdings (Americas) Inc., GlaxoSmithKline, LLC, Pfizer Inc., Sanofi US Services, Inc., Sanofi-Aventis US LLC. (Attachments: #1 Text of Proposed Order)(Odell, Christopher) |
| Filing 16 CORPORATE DISCLOSURE STATEMENT filed by GlaxoSmithKline Holdings (Americas) Inc., GlaxoSmithKline, LLC identifying Corporate Parent GlaxoSmithKline plc for GlaxoSmithKline Holdings (Americas) Inc., GlaxoSmithKline, LLC. (Cohan, Lindsey) |
| Filing 15 Opposed MOTION to Seal Exhibit to Plaintiffs' Expedited Motion to Remand by Jeffrey Alexander Heald, Maria Heald, Nicholas Matthew Heald, Sean Louis Heald. (Attachments: #1 Order Granting)(Hilliard, Robert) |
| Filing 14 NOTICE of Attorney Appearance by Lindsey Beth Cohan on behalf of GlaxoSmithKline Holdings (Americas) Inc., GlaxoSmithKline, LLC (Cohan, Lindsey) |
| Filing 13 SEALED ADDITIONAL ATTACHMENT Exhibit 1 to Main Document: #12 Opposed MOTION to Remand to State Court . (Hilliard, Robert) Modified title on 1/26/2023 (kcv, ). |
| Filing 12 Opposed MOTION to Remand to State Court by Jeffrey Alexander Heald, Maria Heald, Nicholas Matthew Heald, Sean Louis Heald. (Attachments: #1 Exhibit 1. UNDER SEAL, #2 Text of Proposed Order Granting Plaintiffs' Expedited Motion to Remand)(Hilliard, Robert) |
| Filing 11 CORPORATE DISCLOSURE STATEMENT filed by Chattem, Inc., Sanofi US Services, Inc., Sanofi-Aventis US LLC identifying Corporate Parent Sanofi S.A. for Chattem, Inc., Sanofi US Services, Inc., Sanofi-Aventis US LLC. (Al-Hendy, Mohamed) |
| Filing 10 CORPORATE DISCLOSURE STATEMENT filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation identifying Corporate Parent Boehringer Ingelheim International GmbH for Boehringer Ingelheim USA Corporation; Corporate Parent Boehringer Ingelheim Corporation, Corporate Parent Boehringer Ingelheim USA Corporation for Boehringer Ingelheim Pharmaceuticals, Inc.; Corporate Parent Boehringer Ingelheim USA Corporation for Boehringer Ingelheim Corporation. (Renfroe, Tracie) |
|
Filing 9
ORDER directing the parties to conduct a Rule 26(f) Attorney Conference by February 6, 2023. Rule 16 Case Management/Scheduling Conference set for 2/28/2023 10:30 AM in Room 221 before District Judge Michael J. Truncale. Signed by District Judge Michael J. Truncale on 1/18/23. (kcv, )
|
| In accordance with the provisions of 28 USC Section 636(c), you are hereby notified that a U.S. Magistrate Judge of this district court is available to conduct any or all proceedings in this case including a jury or non-jury trial and to order the entry of a final judgment. The form #Consent to Proceed Before Magistrate Judge is available on our website. All signed consent forms, excluding pro se parties, should be filed electronically using the event Notice Regarding Consent to Proceed Before Magistrate Judge. (kcv, ) |
| Remark: The following attorneys were contacted by email on 1/17/2023 regarding admission requirements for the Eastern District of TX: John C. Duff for plaintiffs, Sela A. Garcia for Defendant Pfizer, Inc., and Jenna Johnson for Defendant H-E-B, LP. (kcv, ) |
| Filing 8 ORIGINAL ANSWER to #3 Third Amended Petition filed in State Court and included in the Notice of Removal by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation.(kcv, ) |
| Filing 7 ORIGINAL ANSWER to #3 Third Amended Petition filed in State Court and included in the Notice of Removal by Chattem, Inc., Sanofi US Services, Inc., Sanofi-Aventis US LLC.(kcv, ) |
| Filing 6 ORIGINAL ANSWER to #3 Third Amended Petition filed in State Court and included in the Notice of Removal by GlaxoSmithKline Holdings (Americas) Inc., GlaxoSmithKline, LLC.(kcv, ) |
| Filing 5 ORIGINAL ANSWER to #3 Third Amended Petition filed in State Court and included in the Notice of Removal by Patheon Manufacturing Services LLC.(kcv, ) |
| Filing 4 ORIGINAL ANSWER to #3 Third Amended Petition, filed in State Court and included in the Notice of Removal by Pfizer Inc.(kcv, ) |
| Filing 3 THIRD AMENDED PETITION filed in State Court and included in the Notice of Removal against Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, Chattem, Inc., GlaxoSmithKline Holdings (Americas) Inc., GlaxoSmithKline, LLC, H-E-B, LP, Patheon Manufacturing Services LLC, Pfizer Inc., Sanofi US Services, Inc., Sanofi-Aventis US LLC, filed by Maria Heald, Sean Louis Heald, Nicholas Matthew Heald, Jeffrey Alexander Heald.(kcv, ) Modified on 1/17/2023 (kcv, ). |
| Filing 2 ORIGINAL ANSWER to First Amended Petition filed in State Court and included in the Notice of Removal by H-E-B, LP.(kcv, ) |
| Case Assigned to District Judge Michael J. Truncale. (kcv, ) |
| DEMAND for Trial by Jury. (kcv, ) |
| Filing 1 NOTICE OF REMOVAL by Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation from 136th civil district court of jefferson county, case number D-0209468. (Filing fee $ 402 receipt number ATXEDC-9309163), filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation. (Attachments: #1 Civil Cover Sheet Civil Cover Sheet, #2 Exhibit List of Documents, #3 Exhibit List of Parties and Status, #4 Exhibit All Pleadings, #5 Exhibit Certified Copy of Docket)(Renfroe, Tracie) (Blank attachment 5 replaced on 1/13/2023) (tkd, ). (Blank attachment 5 replaced again on 1/17/2023 due to image error) (kcv, ). |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Texas Eastern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
